T50.992S Poisoning by other drugs, medicaments and biological substances, intentional self-harm, sequela

Name of the Condition

• Poisoning by other drugs, medicaments and biological substances, intentional self-harm, sequela (ICD-10 Code: T50.992S)

Summary

This condition represents the residual effects or complications following intentional self-harm involving exposure to drugs, medicaments, or biological substances categorized as "other" (not specified elsewhere in the ICD-10-CM classification). It is used to document long-term consequences of the initial poisoning event, such as chronic organ damage, persistent symptoms, or functional impairment resulting from the self-harm incident.

Causes

The sequela arises from prior intentional self-harm involving unspecified or other drugs, medicaments, or biological substances. The original event may have included deliberate ingestion, injection, or exposure, with the residual effects now manifesting as ongoing health issues or disability.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety)
• Prior suicide attempts or self-harm behaviors
• Access to medications or substances
• Substance misuse or dependence
• Social isolation or emotional distress

Symptoms

Symptoms depend on the residual effects of the initial poisoning and may include:

• Chronic organ dysfunction (e.g., renal or hepatic impairment)
• Persistent neurological deficits (e.g., cognitive impairment, seizures)
• Gastrointestinal complications (e.g., chronic pain, malabsorption)
• Psychological sequelae (e.g., PTSD, mood disorders)

Diagnosis

Diagnosis is based on clinical evaluation of residual effects following a documented intentional self-harm event involving other drugs or substances. Medical history, prior treatment records, and current symptoms are used to confirm the connection between the initial event and present complications. Imaging or laboratory tests may assess organ damage or functional impairment.

Treatment Options

Management focuses on addressing residual symptoms and preventing further harm. Interventions may include:

• Ongoing medical care for chronic conditions (e.g., organ support, rehabilitation)
• Mental health therapy to address underlying issues
• Medication management for persistent symptoms
• Supportive care to improve quality of life

Prognosis and Follow-Up

Prognosis varies based on the severity of residual effects and the individual’s response to treatment. Regular follow-up is essential to monitor for worsening symptoms, adjust therapies, and provide psychosocial support. Long-term outcomes depend on the extent of organ damage and adherence to treatment plans.

Complications

Potential complications include:

• Progressive organ failure
• Recurrent self-harm or suicidal ideation
• Chronic pain or disability
• Social or occupational impairment

Lifestyle & Prevention

• Secure storage of medications to prevent future access
• Ongoing mental health support and therapy
• Education on substance safety and self-harm risks
• Building a support network to reduce isolation

When to Seek Professional Help

Seek immediate medical attention for:

• Worsening symptoms or new complications
• Signs of recurrent self-harm or suicidal thoughts
• Difficulty managing chronic symptoms or treatment side effects

Tips for Medical Coders

Use T50.992S to document sequelae of intentional self-harm involving other drugs, medicaments, or biological substances. Ensure the code is linked to the original poisoning event and supported by clinical documentation of residual effects. Verify that the sequela is directly attributable to the prior self-harm incident and not a new, unrelated condition.